Peter McFetridge
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Peter McFetridge has a total of 8 co-authors. Here are the top co-authors by number of shared publications:
Blanka Sharma
J. Crayton Pruitt Family Department of Biomedical Engineering University of Florida Gainesville FL 32611 USA
1 shared publicationCamryn Lewis
J. Crayton Pruitt Family Department of Biomedical Engineering University of Florida Gainesville FL 32611 USA
1 shared publicationChristopher Nacea
Department of Materials Science and Engineering University of Florida Gainesville FL 32611 USA
1 shared publicationDayita Wable
J. Crayton Pruitt Family Department of Biomedical Engineering University of Florida Gainesville FL 32611 USA
1 shared publicationIsaac Adjei
J. Crayton Pruitt Family Department of Biomedical Engineering University of Florida Gainesville FL 32611 USA
1 shared publication- Jon Dobson
J. Crayton Pruitt Family Department of Biomedical Engineering, Herbert Wertheim College of Engineering, University of Florida, Gainesville, FL, USA
1 shared publication
Latest Publications
- 4 October 2020
- Published by Wiley in Macromolecular Bioscience
- Vol. 21 (1) , e2000249
Magnetically Responsive Polymeric Microparticles for the Triggered Delivery of a Complex Mixture of Human Placental Proteins
Bone loss through traumatic injury is a significant clinical issue. Researchers have created many scaffold types to mimic an extracellular matrix to provide structural support for the formation of new bone, however functional regeneration of larger scaffolds has not been fully achieved. Newer scaffolds aim to deliver bioactive molecules to improve tissue regeneration. To achieve a more comprehensive regenerative response, a magnetically triggerable polymeric microparticle platform is developed for the on‐demand release of a complex mixture of isolated human placental proteins. This system is composed of polycaprolactone (PCL) microparticles, encapsulating magnetic nanoparticles (MNPs), and placental proteins. When subjected to an alternating magnetic field (AMF), the MNPs heat and melt the PCL, enhancing the diffusion of proteins from microparticles. When the field is off, the PCL re‐solidifies. This potentially allows for cyclic drug delivery. Here the design, synthesis, and proof‐of‐concept experiments for this system are reported. In addition, it is shown that the proteins retain function after being magnetically released. The ability to trigger the release of complex protein mixtures on‐demand may provide a significant advantage with wounds where stagnation of healing processes can occur (e.g., large segmented bone defects).
- 4 October 2020
- Published by Wiley in Macromolecular Bioscience
- Vol. 21 (1) , e2000249
Magnetically Responsive Polymeric Microparticles for the Triggered Delivery of a Complex Mixture of Human Placental Proteins
Bone loss through traumatic injury is a significant clinical issue. Researchers have created many scaffold types to mimic an extracellular matrix to provide structural support for the formation of new bone, however functional regeneration of larger scaffolds has not been fully achieved. Newer scaffolds aim to deliver bioactive molecules to improve tissue regeneration. To achieve a more comprehensive regenerative response, a magnetically triggerable polymeric microparticle platform is developed for the on‐demand release of a complex mixture of isolated human placental proteins. This system is composed of polycaprolactone (PCL) microparticles, encapsulating magnetic nanoparticles (MNPs), and placental proteins. When subjected to an alternating magnetic field (AMF), the MNPs heat and melt the PCL, enhancing the diffusion of proteins from microparticles. When the field is off, the PCL re‐solidifies. This potentially allows for cyclic drug delivery. Here the design, synthesis, and proof‐of‐concept experiments for this system are reported. In addition, it is shown that the proteins retain function after being magnetically released. The ability to trigger the release of complex protein mixtures on‐demand may provide a significant advantage with wounds where stagnation of healing processes can occur (e.g., large segmented bone defects).